From: "Saved by Windows Internet Explorer 7"
Subject: SURGERY'S NEXT STEP: FACE TRANSPLANTS ; The severely disfigured see hope for a normal life, but ethicists fear the risks may be too high - Archives: Chicago Tribune
Date: Mon, 5 May 2008 00:30:53 -0500
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_007C_01C8AE47.46F743A0"
X-MimeOLE: Produced By Microsoft MimeOLE V6.0.6000.16545

This is a multi-part message in MIME format.

------=_NextPart_000_007C_01C8AE47.46F743A0
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://pqasb.pqarchiver.com/chicagotribune/access/852669231.html?dids=852669231:852669231&FMT=FT&FMTS=ABS:FT&type=current&date=Jun+12%2C+2005&author=Peter+Gorner%2C+Tribune+science+reporter&pub=Chicago+Tribune&edition=&startpage=1&desc=SURGERY%27S+NEXT+STEP%3A+FACE+TRANSPLANTS+%3B+The+severely+disfigured+see+hope+for+a+normal+life%2C+but+ethicists+fear+the+risks+may+be+too+high&pf=1

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>SURGERY'S NEXT STEP: FACE TRANSPLANTS ; The severely =
disfigured see hope for a normal life, but ethicists fear the risks may =
be too high - Archives: Chicago Tribune</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252"><LINK=20
href=3D"http://pqasb.pqarchiver.com/chicagotribune/genericstyles.css"=20
type=3Dtext/css rel=3Dstylesheet>
<META content=3D"MSHTML 6.00.6000.16643" name=3DGENERATOR></HEAD>
<BODY bgColor=3D#ffffff>
<DIV style=3D"WIDTH: 640px">
<DIV class=3DdocTitle=20
style=3D"PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 5px">SURGERY'S=20
NEXT STEP: FACE TRANSPLANTS ; The severely disfigured see hope for a =
normal=20
life, but ethicists fear the risks may be too high</DIV>
<DIV class=3Dsub_headline>[Chicago Final Edition]<BR></DIV>
<DIV=20
style=3D"BORDER-RIGHT: #003366 0px solid; PADDING-RIGHT: 0px; =
BORDER-TOP: #003366 0px solid; PADDING-LEFT: 0px; PADDING-BOTTOM: 5px; =
BORDER-LEFT: #003366 0px solid; PADDING-TOP: 5px; BORDER-BOTTOM: #003366 =
0px solid">Chicago=20
Tribune - Chicago, Ill.<BR>
<TABLE cellSpacing=3D0 cellPadding=3D0 border=3D0>
  <TBODY>
  <TR>
    <TD=20
    style=3D"PADDING-RIGHT: 5px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px">Author:</TD>
    <TD>Peter Gorner, Tribune science reporter</TD></TR>
  <TR>
    <TD=20
    style=3D"PADDING-RIGHT: 5px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px">Date:</TD>
    <TD>Jun 12, 2005</TD></TR>
  <TR>
    <TD=20
    style=3D"PADDING-RIGHT: 5px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px">Start=20
      Page:</TD>
    <TD>1</TD></TR>
  <TR>
    <TD=20
    style=3D"PADDING-RIGHT: 5px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px">Section:</TD>
    <TD>News</TD></TR>
  <TR>
    <TD=20
    style=3D"PADDING-RIGHT: 5px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px">Text=20
      Word Count:</TD>
    <TD>1890</TD></TR></TBODY></TABLE></DIV>
<DIV class=3Dmain_bar><B>Document Text</B></DIV>
<DIV=20
style=3D"PADDING-RIGHT: 2px; PADDING-LEFT: 2px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 5px"><!-- google_ad_region_start=3Dpqacontent -->
<P>Ethicists may find the idea unacceptable, but at least two medical =
centers in=20
the U.S. are in the final phases of planning for a controversial new =
procedure:=20
a face transplant.</P>
<P>Surgeons say they are ready to remove the face of a cadaver and =
stitch it=20
onto an adult who has been severely disfigured by trauma, burns or =
tumors. The=20
goal is helping people who often say they are shunned by society and =
lead=20
extremely unhappy lives.</P>
<P>Currently doctors try to reconstruct faces by transplanting tissue =
from other=20
sites on the body in multiple operations-- sometimes 120 or more =
separate=20
surgeries--and by implanting prosthetic devices.</P>
<P>A face transplant would permit surgeons to mold an actual face and =
underlying=20
tissue, which proponents say is closer to what nature intended. They =
want=20
patients to regain the ability to eat, drink and communicate with others =
through=20
the vast array of facial expressions that few people think about unless =
they are=20
lost.</P>
<P>Critics note that face transplants won't save or prolong lives but =
will=20
require recipients to take powerful and perhaps dangerous =
immunosuppressive=20
drugs for the rest of their lives. Such drugs normally are given to =
organ=20
transplant recipients whose only other option is death.</P>
<P>And if the surgery goes wrong--if the body rejects the face, for =
example--the=20
consequences could be dire.</P>
<P>"The risks to the patient are staggering. This is a terrible idea =
that should=20
not be tried," said Arthur Caplan, chairman of bioethics at the =
University of=20
Pennsylvania.</P>
<P>Christine Piff said she used to feel that way. But today she stands =
among the=20
few patient advocates who have come out in favor of the operation.</P>
<P>"When I first heard of face transplants, I was truly horrified. But =
over the=20
years, I met so many miserably unhappy people, I've changed my mind," =
said Piff,=20
an Englishwoman who founded Let's Face It, an international self-help =
network=20
for facially disfigured people.</P>
<P>Piff, whose face was ravaged by surgery on a cancerous tumor in her =
left=20
cheek, said many disfigured people never leave home.</P>
<P>"We don't go out because of the way we look," she said. "We're =
frightened=20
because of how the public stares at us. Children at school are bullied =
if they=20
look different. Society tends to be very cruel if you don't look the =
same.</P>
<P>"So disfigured people just shut themselves away. They only leave home =
at=20
night with hoods over their faces. For them, face transplants could mean =
a=20
chance at a normal life."</P>
<P>Surgeons make case</P>
<P>Transplant surgeons say the operation would allow the patient's face =
to move=20
instead of being like an insensitive mask, which is often the case after =
skin=20
grafts.</P>
<P>The new face would probably resemble a cross between the donor and =
recipient,=20
depending on the amount of facial muscles used in the operation. A =
person's=20
facial identity is mostly determined by the underlying skull, which =
would not be=20
transplanted.</P>
<P>The surgeons say they can perform the surgery and are tired of being =
stymied=20
by the squeamish.</P>
<P>"It's time to do face transplant. Technically, it could have been 10 =
years=20
ago," said Dr. John H. Barker, director of plastic surgery research at =
the=20
University of Louisville, which performed the nation's first hand =
transplant in=20
1999.</P>
<P>He is seeking permission from his institution to perform 10 face =
transplants,=20
all on severely burned victims.</P>
<P>"Before we did the hand, there was rat, rabbit and pig research =
saying it=20
would work. And there was a lot of ethical debate advising against it," =
Barker=20
said. "Now, there have been 25 hands transplanted in 19 human beings, =
some out=20
five years post- transplant."</P>
<P>The success of hand transplants suggests that face transplants would =
work,=20
since both operations involve multiple tissues--skin, muscles, bones, =
tendons,=20
cartilage, fat, nerves and blood vessels. The drugs that would be used =
to=20
prevent rejection are being safely used by thousands of kidney =
transplant=20
patients, Barker said.</P>
<P>"Face transplants will be done," he said. "There is a great need. =
There may=20
be ethical issues, but there comes a point where you've got to just do =
it, and=20
let the cards fall where they may."</P>
<P>Ethicists say the risks are just too great. Given the potential =
problems--the=20
possibility of tissue rejection, side effects of anti- rejection drugs,=20
unforeseen psychological difficulties--a high price could be paid for =
the hope=20
of looking normal.</P>
<P>"It's not certain that the transplant will provide a functioning or =
even=20
partial-functioning face," Caplan said. "The drugs required are =
powerful,=20
noxious and potentially life-threatening."</P>
<P>No one knows for sure how the body's immune system will react to a =
new face.=20
If acute rejection occurs shortly after surgery, "the subject may die =
with the=20
entire graft sloughing off his or her face," Caplan said.</P>
<P>'Not for vanity'</P>
<P>Transplant surgeons say such comments are made by individuals with no =

experience in this field. Their first "rescue strategy" would be to =
transplant=20
another face; otherwise, they would revert to normal reconstruction=20
procedures.</P>
<P>"It's essential that people understand this surgery is not for =
vanity. The=20
people seeking facial transplants are isolated and desperate," said Dr. =
Maria=20
Siemionow, director of plastic surgery research and training for the =
Cleveland=20
Clinic Foundation.</P>
<P>In October, her institution became the first in the U.S. to give =
permission=20
for face transplants and allowed her to start screening patients. =
Transplant=20
surgeons agree that only people who have specifically agreed in advance =
to be=20
face donors would be considered. Potential recipients would undergo =
intense=20
psychological evaluation.</P>
<P>Siemionow has published hundreds of studies about circulation and the =

successful transplantation of face, limbs and other tissue in laboratory =

animals. Mock transplants performed on cadavers have taught her the =
amount of=20
tissue required in such surgery on humans, she said.</P>
<P>Her 15 years of research is evidenced by the white lab rats with =
brown=20
faces--and half-brown faces--that occupy cages in her lab.</P>
<P>"The procedure is very difficult," Siemionow said. "It takes more =
than 6 1/2=20
hours to transplant a full facial graft in a rat. The hemi-face is a =
shorter=20
procedure to test rejection events."</P>
<P>She is trying to develop a process that would head off the need for=20
anti-rejection drugs by giving transplant recipients special antibodies =
in=20
advance. The idea has been tested in animals but so far is not =
transferable to=20
humans.</P>
<P>"Currently, the rats receive only seven days of medication and will =
accept a=20
leg from another rat for life," Siemionow said. "I'm not saying that =
face=20
transplants should wait until we figure this out. I'm saying that our =
work in=20
induced-tolerance should be considered by those who have doubts about =
the future=20
of this line of research."</P>
<P>Some critics point out that a face transplant is not necessary to =
preserve=20
life. But that objection has not prevented other types of transplants =
from being=20
performed in various countries, including hand transplants, abdominal =
wall=20
transplants, a larynx transplant that enabled the recipient to speak, =
and the=20
first total tongue transplant.</P>
<P>Even if the first operations went well, Caplan said the possible =
impact on=20
organ donation must be considered.</P>
<P>"Most donation involves organs and tissues that can be removed from a =
cadaver=20
without causing grave disfigurement to the body," he said. "This will =
not be=20
true of face donation. ... There could be an adverse impact on the =
public's=20
willingness to support organ and tissue donation."</P>
<P>The issue of informed consent by face transplant recipients could be =
another=20
problem, ethicists observed.</P>
<P>"They may be so desperate to do something about their severe =
disfigurement=20
that they'll clutch at straws," said Carson Strong, of the University of =

Tennessee College of Medicine.</P>
<P>"I don't think we'd be able to make sure that wasn't the case with =
any=20
particular patient."</P>
<P>Medical teams in Europe also hope to perform the procedure. In =
Britain, an=20
influential working party report from the Royal College of Surgeons =
advised in=20
November 2003 that although it was optimistic about the idea, "it would =
be=20
unwise to proceed with human facial transplantation" until more=20
research--psychological as well as physiological--is done.</P>
<P>The following March, an ethics board in France rejected a face =
transplant=20
proposal, even though that country had performed the world's first hand=20
transplant.</P>
<P>Doubts and divisions</P>
<P>Conflicts in the field are evident. For example, the U.S. director =
for the=20
international support group founded by Piff said she sees little need =
for facial=20
transplantation because other steps can be taken.</P>
<P>Rickie Gill, executive director of Batavia-based AboutFace USA, has a =
son who=20
was born with a severe birth defect that required his entire face and =
cranium to=20
be reconstructed many times as he grew up.</P>
<P>"It would have to be a terrible, terrible reason to even consider =
having=20
somebody slice off your face," she said.</P>
<P>"In fairness to transplant advocates, we also live with this =
situation every=20
day," Gill added. "I'm open to anything that will save these =
patients--be they=20
children or adults--from any more pain than they must endure, either =
emotionally=20
or physically."</P>
<P>Piff suffered a cancerous tumor in her left cheek 28 years ago, when =
she was=20
36 and had three young children. When chemotherapy and radiotherapy were =

unsuccessful, Piff underwent an operation called maxillectomy.</P>
<P>"My kids gave me no choice," she said. "I had to live."</P>
<P>The operation cost Piff her left eye; half her palate, which held her =
upper=20
teeth; and the maxilla bone, or upper jaw.</P>
<P>Coming out of surgery, she remembers a nurse's lulling voice: =
"'Christine,=20
you still have got your eye.' I smiled a big smile and my teeth fell =
onto my=20
chin," she wrote in an essay.</P>
<P>Piff wears a masklike facial prosthesis and an artificial palate that =
enables=20
her to eat, drink and speak.</P>
<P>As she worked through the grief over her lost face and her =
insecurities about=20
how she looked, Piff found there was little help available for people =
like her.=20
In 1984 she founded Let's Face It. The group quickly spread to the =
United=20
States, Australia, Germany, Denmark, Sweden and Norway.</P>
<P>"People who are shut away don't have much of a life," Piff said. =
"These are=20
the patients, I think, who would really benefit from facial=20
transplantation."</P>
<P>pgorner@tribune.com</P>
<P>- - -</P>
<P>Face transplant procedure nears reality</P>
<P>Surgeons at two U.S. medical institutions say they are ready to mold =
facial=20
tissue of human donors onto severely disfigured adults. The goal is to =
provide=20
greater mobility of the face and help those who feel isolated from =
society.=20
Critics, however, say the risks are too high.</P>
<P>RETRIEVING DONOR TISSUE</P>
<P>Incisions are made on the donor's face, in this case, from just below =
the=20
hairline to below the chin. The skin and underlying tissue is removed. =
Surgeons=20
will use as much of the recipient's healthy tissue as possible.</P>
<P>The time limit between removing tissue and reconnecting it is about =
10 to 15=20
hours, the length skin can last without blood nourishment.</P>
<P>PREPARING THE RECIPIENT</P>
<P>Surgeons remove the face of the recipient, clamping off crucial veins =
and=20
arteries to block the blood flow. Ideally, the eyelids are still intact =
as they=20
are the most complicated to reattach.</P>
<P>Bone grafts may be required.</P>
<P>TRANSPLANTATION</P>
<P>In a 12- to 24-hour procedure, microsurgeons attach the recipient's =
severed=20
arteries and veins to the donor's facial tissue. The nerves are =
connected, then=20
the muscles and skin.</P>
<P>Sources: Popular Mechanics, KO Studios, The Royal College of Surgeons =
of=20
England; Dr. John H. Barker, University of Louisville</P>
<P>Los Angeles Times/Chicago Tribune</P>
<P>-See microfilm for complete graphic.</P>
<P></P>
<DIV style=3D"CLEAR: left"></DIV><!-- google_ad_region_end=3Dpqacontent =
-->
<DIV class=3Dcopyright>Reproduced with permission of the copyright =
owner. Further=20
reproduction or distribution is prohibited without =
permission.</DIV></DIV>
<DIV class=3Dmain_bar><B>Abstract</B> (Document Summary)</DIV>
<DIV=20
style=3D"PADDING-RIGHT: 2px; PADDING-LEFT: 2px; PADDING-BOTTOM: 5px; =
PADDING-TOP: 5px">
<P>Some critics point out that a face transplant is not necessary to =
preserve=20
life. But that objection has not prevented other types of transplants =
from being=20
performed in various countries, including hand transplants, abdominal =
wall=20
transplants, a larynx transplant that enabled the recipient to speak, =
and the=20
first total tongue transplant.</P>
<DIV style=3D"CLEAR: left"></DIV>
<DIV class=3Dcopyright>Reproduced with permission of the copyright =
owner. Further=20
reproduction or distribution is prohibited without=20
permission.</DIV></DIV></DIV></BODY></HTML>

------=_NextPart_000_007C_01C8AE47.46F743A0
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://pqasb.pqarchiver.com/chicagotribune/genericstyles.css

LI {
=09
}
IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
DIV {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
BODY {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
P {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
TD {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
BLOCKQUOTE {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.default {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.caption {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.desc {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.input {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.navlink {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.result_num {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.result_title {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.docAuthline {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.error_msg {
	BORDER-RIGHT: #ff0000 4px double; PADDING-RIGHT: 5px; BORDER-TOP: =
#ff0000 4px double; PADDING-LEFT: 5px; FONT-WEIGHT: bold; =
PADDING-BOTTOM: 5px; BORDER-LEFT: #ff0000 4px double; COLOR: #ff0000; =
PADDING-TOP: 5px; BORDER-BOTTOM: #ff0000 4px double
}
.invalid {
	FONT-WEIGHT: bold; FONT-SIZE: 12px; COLOR: red; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.footnote {
	FONT-SIZE: 10px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.copyright {
	FONT-SIZE: 10px; FONT-FAMILY: arial,verdana,helvetica,sans-serif
}
.resultslegend {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif; =
TEXT-DECORATION: none
}
.resultsheader {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif; =
TEXT-DECORATION: none
}
.docHeading {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif; =
TEXT-DECORATION: none
}
.docText {
	FONT-SIZE: 12px; FONT-FAMILY: arial,verdana,helvetica,sans-serif; =
TEXT-DECORATION: none
}
.pagetitle {
	FONT-WEIGHT: bold; FONT-SIZE: 16px; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.docTitle {
	FONT-WEIGHT: bold; FONT-SIZE: 16px; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.sub_headline {
	FONT-WEIGHT: normal; FONT-SIZE: 13px; FONT-STYLE: italic; FONT-FAMILY: =
arial,helvetica,geneva,sans-serif
}
.emphasis {
	FONT-WEIGHT: bold; COLOR: #0000cc
}
.subdued {
	FONT-SIZE: 12px; COLOR: #808080; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.navtext {
	FONT-WEIGHT: bold; FONT-SIZE: 12px; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.result_extrainfo {
	FONT-SIZE: 12px; COLOR: #777777; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
.title-white {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif
}
A.tab {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif; TEXT-DECORATION: none
}
A.tab:link {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif; TEXT-DECORATION: none
}
A.tab:visited {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif; TEXT-DECORATION: none
}
A.tab:active {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif; TEXT-DECORATION: none
}
A.tab:hover {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #ffffff; FONT-FAMILY: =
arial,verdana,helvetica,sans-serif; TEXT-DECORATION: none
}
A.resultsheader:link {
=09
}
A.resultsheader:visited {
=09
}
A.resultsheader:active {
=09
}
A.resultsheader:hover {
=09
}
.form_title {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; FONT-WEIGHT: bold; FONT-SIZE: =
10pt; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: top; WIDTH: 805px; COLOR: =
#ffffff; PADDING-TOP: 2px; BORDER-BOTTOM: #000000 1px solid; =
FONT-FAMILY: arial; BACKGROUND-COLOR: #003366; TEXT-ALIGN: center
}
.form_title_half {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; FONT-WEIGHT: bold; FONT-SIZE: =
10pt; PADDING-BOTTOM: 2px; VERTICAL-ALIGN: top; WIDTH: 805px; COLOR: =
#ffffff; PADDING-TOP: 2px; BORDER-BOTTOM: #000000 1px solid; =
FONT-FAMILY: arial; BACKGROUND-COLOR: #003366; TEXT-ALIGN: center
}
.form_body {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; FONT-SIZE: 10pt; PADDING-BOTTOM: =
2px; WIDTH: 805px; PADDING-TOP: 2px; FONT-FAMILY: arial; =
BACKGROUND-COLOR: #f0f0f0
}
.form_body_half {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; FONT-SIZE: 10pt; PADDING-BOTTOM: =
2px; WIDTH: 805px; PADDING-TOP: 2px; FONT-FAMILY: arial; =
BACKGROUND-COLOR: #f0f0f0
}
.form_body_half {
	WIDTH: 398px
}
.form_title_half {
	WIDTH: 398px
}
.white_matte {
	BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; =
DISPLAY: block; BORDER-LEFT: #000000 1px solid; WIDTH: 50px; =
BORDER-BOTTOM: #000000 1px solid; HEIGHT: 15px; BACKGROUND-COLOR: =
#ffffff; TEXT-ALIGN: center
}
.cream_matte {
	BORDER-RIGHT: #000000 1px solid; BORDER-TOP: #000000 1px solid; =
DISPLAY: block; BORDER-LEFT: #000000 1px solid; WIDTH: 50px; =
BORDER-BOTTOM: #000000 1px solid; HEIGHT: 15px; BACKGROUND-COLOR: =
#ffffff; TEXT-ALIGN: center
}
.cream_matte {
	BACKGROUND-COLOR: #fff8dc
}
DIV#pp_sample {
	BACKGROUND-IMAGE: url(/chicagotribune/main/art/black_frame.gif); WIDTH: =
327px; BACKGROUND-REPEAT: no-repeat; HEIGHT: 402px; BACKGROUND-COLOR: =
#ffffff
}
DIV.pp_sample_small {
	BACKGROUND-IMAGE: url(/chicagotribune/main/art/black_frame_small.gif); =
WIDTH: 81px; BACKGROUND-REPEAT: no-repeat; HEIGHT: 100px; =
BACKGROUND-COLOR: #ffffff
}
TABLE.cart {
	BORDER-COLLAPSE: collapse
}
TH.cart {
	PADDING-RIGHT: 8px; PADDING-LEFT: 8px; PADDING-BOTTOM: 2px; =
PADDING-TOP: 2px
}
TD.cart {
	PADDING-RIGHT: 8px; PADDING-LEFT: 8px; PADDING-BOTTOM: 2px; =
PADDING-TOP: 2px
}
DIV#short_submit {
	VISIBILITY: hidden
}
.list {
	BORDER-RIGHT: #000000 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: =
#000000 1px solid; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; BORDER-LEFT: =
#000000 1px solid; PADDING-TOP: 2px; BORDER-BOTTOM: #000000 1px solid; =
BACKGROUND-COLOR: #ffffff
}
.list_alt {
	BORDER-RIGHT: #000000 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: =
#000000 1px solid; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; BORDER-LEFT: =
#000000 1px solid; PADDING-TOP: 2px; BORDER-BOTTOM: #000000 1px solid; =
BACKGROUND-COLOR: #ffffff
}
.list_alt {
	BACKGROUND-COLOR: #e9e9e9
}
TABLE.display {
	WIDTH: 100%; BORDER-COLLAPSE: collapse
}
TABLE.display TH {
	BORDER-RIGHT: #003366 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: =
#003366 1px solid; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; =
VERTICAL-ALIGN: top; BORDER-LEFT: #003366 1px solid; PADDING-TOP: 2px; =
BORDER-BOTTOM: #003366 1px solid
}
TABLE.display TD {
	BORDER-RIGHT: #003366 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: =
#003366 1px solid; PADDING-LEFT: 4px; PADDING-BOTTOM: 2px; =
VERTICAL-ALIGN: top; BORDER-LEFT: #003366 1px solid; PADDING-TOP: 2px; =
BORDER-BOTTOM: #003366 1px solid
}
SPAN.value_text {
	FONT-WEIGHT: bold
}
TABLE.box {
	BORDER-RIGHT: #003366 1px solid; BORDER-TOP: #003366 1px solid; =
BORDER-LEFT: #003366 1px solid; WIDTH: 100%; BORDER-BOTTOM: #003366 1px =
solid; BORDER-COLLAPSE: collapse
}
TABLE.box TH {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 5px; PADDING-LEFT: 5px; =
FONT-WEIGHT: bold; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; =
PADDING-BOTTOM: 1px; COLOR: #ffffff; PADDING-TOP: 1px; BACKGROUND-COLOR: =
#003366; TEXT-ALIGN: left; BORDER-RIGHT-WIDTH: 0px
}
TABLE.box TD {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 5px; PADDING-LEFT: 5px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 1px; =
VERTICAL-ALIGN: top; PADDING-TOP: 1px; BACKGROUND-COLOR: #f0f0f0; =
BORDER-RIGHT-WIDTH: 0px
}
TABLE.noborder TD {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 2px; =
VERTICAL-ALIGN: top; COLOR: #000000; PADDING-TOP: 2px; =
BORDER-RIGHT-WIDTH: 0px
}
TABLE.noborder TH {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 2px; =
VERTICAL-ALIGN: top; COLOR: #000000; PADDING-TOP: 2px; =
BORDER-RIGHT-WIDTH: 0px
}
TABLE.noborder TH {
	FONT-WEIGHT: bold; BORDER-LEFT-COLOR: #cccccc; BORDER-BOTTOM-COLOR: =
#cccccc; BORDER-TOP-COLOR: #cccccc; BACKGROUND-COLOR: #cccccc; =
TEXT-ALIGN: center; BORDER-RIGHT-COLOR: #cccccc
}
TH.offset {
	BACKGROUND-COLOR: #003366
}
TH.offset A {
	COLOR: #ffffff
}
DIV.form_fail {
	BORDER-RIGHT: #f00 1px solid; PADDING-RIGHT: 4px; BORDER-TOP: #f00 1px =
solid; PADDING-LEFT: 4px; FONT-WEIGHT: bold; PADDING-BOTTOM: 4px; =
MARGIN: 20px 0px; BORDER-LEFT: #f00 1px solid; WIDTH: 810px; COLOR: =
#ff0000; PADDING-TOP: 4px; BORDER-BOTTOM: #f00 1px solid
}
.link_gold {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_white {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_gold:visited {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_gold:active {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_gold:link {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_white:active {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_white:active {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_white:link {
	FONT-SIZE: 10px; FONT-VARIANT: small-caps; TEXT-DECORATION: none
}
.link_gold {
	COLOR: #ffcc33
}
.link_gold:visited {
	COLOR: #ffcc33
}
.link_gold:active {
	COLOR: #ffcc33
}
.link_gold:link {
	COLOR: #ffcc33
}
.link_white {
	COLOR: #ffffff
}
.link_white:active {
	COLOR: #ffffff
}
.link_white:active {
	COLOR: #ffffff
}
.link_white:link {
	COLOR: #ffffff
}
.main_bar {
	BORDER-RIGHT: #003366 0px solid; PADDING-RIGHT: 5px; BORDER-TOP: =
#003366 1px solid; PADDING-LEFT: 5px; PADDING-BOTTOM: 5px; BORDER-LEFT: =
#003366 0px solid; PADDING-TOP: 5px; BORDER-BOTTOM: #003366 1px solid; =
BACKGROUND-COLOR: #c0c0c0
}
.doc_action_labels {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-SIZE: 11px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-DECORATION: none
}
.doc_action_labels A {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; FONT-SIZE: 11px; =
PADDING-BOTTOM: 0px; PADDING-TOP: 0px; TEXT-DECORATION: none
}
.doc_action_labels A {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
.doc_action_labels A:hover {
	TEXT-DECORATION: underline
}
IMG.format_icon {
	BORDER-TOP-WIDTH: 0px; PADDING-RIGHT: 2px; PADDING-LEFT: 2px; =
BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; PADDING-BOTTOM: 0px; =
WIDTH: 22px; PADDING-TOP: 0px; HEIGHT: 18px; BORDER-RIGHT-WIDTH: 0px
}
A#leftnav-dark {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #003366; LINE-HEIGHT: 11px; =
FONT-FAMILY: arial, helvetica, sans-serif; TEXT-DECORATION: none
}
A#leftnav-dark:link {
	COLOR: #003366
}
A#leftnav-dark:visited {
	COLOR: #003366
}
A#leftnav-dark:active {
	COLOR: #003366
}
A#leftnav-dark:hover {
	COLOR: #666666; TEXT-DECORATION: underline
}
A.navlink {
	FONT-SIZE: 11px; COLOR: #003366; LINE-HEIGHT: 11px; FONT-FAMILY: arial, =
helvetica, sans-serif; TEXT-DECORATION: none
}
A.navlink:link {
	COLOR: #003366
}
A.navlink:visited {
	COLOR: #003366
}
A.navlink:active {
	COLOR: #003366
}
A.navlink:hover {
	COLOR: #666666; TEXT-DECORATION: underline
}
#utility-description {
	FONT-SIZE: 11px; FONT-FAMILY: arial, helvetica, sans-serif
}

------=_NextPart_000_007C_01C8AE47.46F743A0--
